Biotech · Private company
Cancer Insight, LLC
Track this companyFree. Adds Cancer Insight, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- GM-CSFPhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- NeuVax vaccinePhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- TrastuzumabPhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Gemcitabine (gem) (Cohort A, B and C)Phase 1 · Metastatic Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Hydroxychloroquine (HCQ) (Cohort B)Phase 1 · Metastatic Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Ipilimumab (Cohort A, B and C)Phase 1 · Metastatic Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Nab-paclitaxel (nP) (Cohort A, B and C)Phase 1 · Metastatic Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- NG350A (Cohort C)Phase 1 · Metastatic Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Nivolumab (Cohort A)Phase 1 · Metastatic Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic AdenocarcinomaPHASE1 · COMPLETED · started Aug 9, 2021ClinicalTrials.gov NCT04787991 · fetched Nov 12, 2026
- Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active SurveillancePHASE2 · COMPLETED · started Jan 18, 2021ClinicalTrials.gov NCT04230499 · fetched Nov 12, 2026
- Trial of eRapa in Prostate Cancer PatientsPHASE1 · COMPLETED · started Aug 28, 2018ClinicalTrials.gov NCT03618355 · fetched Nov 12, 2026
- SV-BR-1-GM in Metastatic or Locally Recurrent Breast CancerPHASE1_PHASE2 · COMPLETED · started May 5, 2017ClinicalTrials.gov NCT03066947 · fetched Nov 12, 2026
- Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer PatientsPHASE2 · COMPLETED · started Oct 1, 2014ClinicalTrials.gov NCT02297698 · fetched Nov 12, 2026